• O-GlcNAcylation Modulates Ferroptosis in Preeclampsia via HU

  2026-05-06

  This study reveals that O-GlcNAc modification of HUWE1 regulates the ubiquitination and degradation of transferrin receptor 1 (TfR1), suppressing ferroptosis and supporting trophoblast syncytialization in preeclampsia. These mechanistic insights highlight a novel O-GlcNAc–HUWE1–TfR1 pathway, suggesting new directions for targeted placental and ferroptosis research.

• Tunicamycin: N-Glycosylation Inhibitor for Advanced ER Stres

  2026-05-06

  Tunicamycin’s precise N-glycosylation inhibition empowers researchers to dissect ER stress, inflammation suppression, and protein homeostasis in both cellular and animal models. This article delivers actionable workflows, optimization tips, and a translational bridge from the latest C. elegans cadmium resistance study to mammalian assay design.

• RITA (NSC 652287): Applied Workflows in Renal Carcinoma Rese

  2026-05-05

  RITA (NSC 652287) enables highly selective p53 activation and robust cytotoxicity in renal carcinoma models, standing out for its nanomolar potency and reliability in apoptosis and xenograft workflows. This guide details practical protocols, troubleshooting, and unique insights from recent research to maximize experimental success.

• LMO2-LDB1 Complex Drives AML Progression: Mechanistic Insigh

  2026-05-05

  This study elucidates the oncogenic role of the LMO2-LDB1 protein complex in acute myeloid leukemia (AML), demonstrating that LDB1 is essential for AML cell proliferation and survival. The findings highlight the potential of targeting this complex for therapeutic intervention.

• Applied Workflows with S-Adenosylmethionine for Methylation

  2026-05-04

  S-Adenosylmethionine (Ademetionine) is a cornerstone reagent for methylation studies in neuroscience and epigenetics, offering unmatched versatility in DNA, RNA, and protein methylation assays. This article details optimized protocols, advanced troubleshooting, and strategic insights for leveraging SAM in experimental and translational research.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-05-04

  Schwartz's dissertation introduces improved in vitro methods for accurately distinguishing between cell proliferation arrest and cell death in response to cancer drugs. This technical innovation refines drug efficacy assessment and has practical implications for optimizing preclinical workflows in cancer pharmacology.

• Vincristine Sulfate: Strategic Mechanisms in Translational O

  2026-05-03

  This article delivers a systems-level analysis of vincristine sulfate’s mechanistic power as a microtubule disrupter, while equipping translational researchers with strategic guidance for experimental design and clinical translation. Integrating recent literature, competitive benchmarking, and evidence-backed protocol parameters, we highlight how APExBIO’s Vincristine sulfate advances cancer research and drug development, moving beyond conventional summaries to chart new directions for oncology workflows.

• α-Amanitin: Elevating Transcriptional Regulation Research

  2026-05-02

  α-Amanitin empowers researchers to dissect RNA polymerase II-dependent processes with unmatched specificity. Discover precise workflows, real-world troubleshooting, and protocol enhancements that leverage APExBIO’s validated α-Amanitin for advanced gene expression pathway analysis and developmental investigations.

• Risedronate Sodium: Precision Targeting of Bone and Tumor Mi

  2026-05-02

  Explore the advanced use of Risedronate Sodium as a FPP synthase inhibitor in bone metabolism and cancer research. This article reveals novel insights into microenvironment modulation, protocol optimization, and translational applications distinct from existing reviews.

• MBD2c Modulates mtDNA Transcription and Drug Resistance in T

  2026-05-01

  This study reveals that the mitochondrial-localized isoform MBD2c enhances mtDNA transcription and mitochondrial respiration in triple-negative breast cancer (TNBC) cells, directly linking epigenetic regulation to metabolic adaptation and drug resistance. The work identifies previously uncharacterized mechanisms underlying mitochondrial gene expression control, with implications for targeting metabolic vulnerabilities in cancer.

• Optimizing Gene Delivery: EZ Cap™ Cy5 EGFP mRNA (5-moUTP) in

  2026-04-30

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers next-generation, non-viral gene delivery in blood cell therapy. This article goes beyond dual-fluorescence tracking to dissect electroporation strategies, immune evasion, and practical workflow design.

• Isoprinosine in Immunotherapy: Mechanistic Leverage and Stra

  2026-04-30

  This thought-leadership article explores how Isoprinosine (inosine pranobex) bridges mechanistic advances in herpesvirus biology—such as CLCC1-mediated nuclear egress—with translational immunotherapy for acute respiratory viral infections. By synthesizing recent findings, benchmarking against the competitive landscape, and offering calibrated protocol guidance, this analysis empowers translational researchers to strategically deploy Isoprinosine as an immunomodulatory agent with proven safety and antiviral efficacy.

• InstaBlue Protein Stain Solution: Rapid Coomassie Gel Staini

  2026-04-29

  InstaBlue Protein Stain Solution enables fast, sensitive, and non-toxic visualization of proteins in polyacrylamide gels, streamlining protein electrophoresis analysis for biomedical research. It eliminates fixation, washing, and destaining, but is not suitable for non-polyacrylamide matrices or workflows requiring organic solvent fixation.

• ATRNL1 Identified as Key Driver in Atrial Fibrillation via s

  2026-04-29

  This study utilizes large-scale single-nucleus RNA sequencing to reveal cell-type-specific transcriptional changes in atrial fibrillation (AF), pinpointing ATRNL1 as a critical modulator in cardiomyocyte stress response and electrical remodeling. The findings advance mechanistic understanding of AF and suggest new avenues for personalized therapeutic strategies.

• Endothelial Sp1/Sp3 Mediate ACE Inhibitor Effects on Hyperte

  2026-04-28

  This study uncovers the critical role of endothelial transcription factors Sp1 and Sp3 in mediating the antihypertensive and vascular protective actions of the ACE inhibitor captopril in male mice. The findings highlight Sp1/Sp3 as essential molecular targets in hypertension mechanism studies and inform future cardiovascular remodeling research.

449 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page